Table 2 Wrap up data of hospitalized patients with Pediatric Inflammatory Multisystem Syndrome (PIMS) Associated with SARS -CoV-2, N: 10

Gender: girl/boy

4/6

lymphocyte < 1000/µL

8

COVID-19 RT-PCR

3

Age

5.37 ± 3.9 (13 months to 12 years old)

Hb < 10 g/dl

8

COVID antibodies

3

Clinical Data

Plt < 100,000/µL

3

Just chest CT-scan

4

Duration of fever

9.4 ± 1.77 (6–12) days

ESR > 30 mm/hour

9

Treatments

Skin rash (Total)

Maculopapular

Target shape

8

8

2

CRP > 10 mg/L

10

Antibiotics

10

Albumin < 3 g/dL

8

Hydroxychoroquine

9

AST or ALT > 50 U/L

2

Packed cell

7

Conjunctivitis(Total)

Purulent

Non-purulent

3

2

1

Blood group/RH

A+

B+

O+

NA

1

2

4

3

Albumin

7

Respiratory symptom (Total)

At admission

During admission

8

3

8

IVIG 1 g/kg

6

IVIG 2 g/kg

3

steroid

2

Vasoactive drugs

4

Imaging Data

Infliximab

1

Ear drum erythema

3

Plural effusion

4

Hospital stay

Oral mucosal change

4

Intra-abdominal fluid

5

PICU stay (9)

7.8 ± 5.2 days (2–20 days)

Gastrointestinal involvement (Total)

Vomiting

Diarrhea

Abdominal pain

9

5

6

7

Abnormal coronary arteries^a

3

Total hospital stay

11 ± 5.5 (3–24) days

Edema

6

Low cardiac ejection fraction^a

3

First impression

Chest CT-scan^b

Normal at admission time

COVID-19 Compatible at the admission time

Became COVID-19 compatible in the days after

8

2

5

Acute hemorrhagic edema of infancy

1

Appendicitis

1

COVID-19

1

Seizure

1

Kawasaki disease

2

Myocarditis

1

Prolonged febrile seizure

1

Sepsis

1

Lymphadenopathy

0

Toxic shock syndrome

1

Acute Renal failure

2

Urosepsis

1

Shock

2